TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
INFU

InfuSystems Holdings Inc

Healthcare · Medical Devices

12.70$ -0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow INFU
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – +149.0% -10.9% +11.4% -33.7% -24.0% +36.9% -2.8% -2.8% +12.1% -4.1% +50.2% +21.8% +46.2% -9.7% -4.4% -35.9% +82.3% +19.3%
– – -87.1% +642.9% +0.6% +33.4% +5.3% -7.1% -4.4% -23.5% +34.2% +30.3% +16.6% -9.7% +9.1% +13.6% +4.3% -8.6% -6.4% -0.1% +6.4%
– – -100.0% -11.4% -51.4% +412.6% -69.3% -18.6% +16.2% -48.6% +72.9% -53.6% +47.6% +40.3% +4.2% +161.8% +145.4% -40.3% +6.5% +9.5% -2.2%
– – – – – – – -91.4% +58.9% +4.1% +1.1% -26.0% +301.2% -71.1% -94.7% -3,143.0% – -23.5% – – –
– -8,983.0% – – – – – – – – – – – – – – – – -1,544.7% – -114.4%
– – – +213.4% +166.1% -47.0% +127.2% +17.8% -8.9% +62.8% +5.6% -14.2% -59.1% +131.0% +172.1% -25.1% -1.5% -9.5% -26.3% +60.4% -51.3%
– – – -104.7% +341.7% +313.4% -70.9% -53.9% -15.5% +31.3% +319.6% -55.1% – -573.3% +294.1% -38.1% +75.3% -46.2% -41.3% +96.6% -48.7%
– – – – – – – – – – – – – – – -24.6% +491.6% +20.6% +215.1% – –
– – – – – +20.5% +97.9% -69.0% -45.1% +158.2% -12.3% -58.1% -22.7% +17,943.1% -93.1% +139.1% +1.1% +284.1% -80.3% +52.3% +449.8%
– – – – – – – – -126.0% -24.6% – -102.2% +7,477.2% – -201.2% – -1,443.7% +668.6% -90.6% +34.7% -22.4%
– +719,076.0% -123.3% -89.9% +285.2% – -205.8% -76.6% +374.7% -22.3% – -99.7% -57,200.0% -35.1% – -127.3% +478.6% -6.2% -27.0% +56.5% +116.0%
– +2,944.8% +753.8% +113.8% -149.8% – – – -177.8% – – +751.5% -97.2% +1,095.8% -296.8% – -235.2% – – +348.5% +798.3%
– – – +139.6% -44.4% +64.2% -80.7% -167.3% – -263.2% – – – -22.6% -382.4% – -50.7% +47.0% -95.7% +2,377.4% +498.7%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?